Publication:
General Approach to Diagnosis and Treatment of Multiple Sclerosis in Turkey

dc.authorwosidTerzi̇, Murat/Aaa-1284-2021
dc.contributor.authorTerzi, Murat
dc.contributor.authorCelik, Yahya
dc.contributor.authorKilinc, Munire
dc.contributor.authorSeleker, Feray
dc.contributor.authorIsik, Nihal
dc.contributor.authorGedizlioglu, Muhtesem
dc.contributor.authorZorlu, Yasar
dc.date.accessioned2025-12-11T00:41:20Z
dc.date.issued2009
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Terzi, Murat] Univ Ondokuz Mayis, Dept Neurol, Fac Med, TR-55160 Kurupelit, Samsun, Turkey; [Celik, Yahya] Trakya Univ, Dept Neurol, Fac Med, Edirne, Turkey; [Kilinc, Munire] Univ Baskent, Dept Neurol, Fac Med, Ankara, Turkey; [Seleker, Feray] Sisli Etfal Training & Res Hosp, Neurol Clin, Istanbul, Turkey; [Isik, Nihal] Goztepe Training & Res Hosp, Neurol Clin, Istanbul, Turkey; [Gedizlioglu, Muhtesem] Izmir Training & Res Hosp, Neurol Clin, Izmir, Turkey; [Zorlu, Yasar] Tepecik Training & Res Hosp, Neurol Clin, Izmir, Turkeyen_US
dc.description.abstractObjective: The clinical progress of multiple sclerosis (MS), initial symptoms and problems during the course of a disease that can be seen, may vary among the patients. Therefore, different applications occurs in the disease diagnosis and treatment plan. The difficulties of diagnosis, treatment and progress of MS disease, experienced by the neurology residents and experts from different regions of the Turkey is intended to introduce. Materials and Methods: Interactive meetings was arrenged in total 11 cities from different regions of Turkey, between March 2008 and June 2008. The data obtained as a result of the responses of participants were evaluated. Results: Neurology specialist and research assistant, total of 242 persons participated. It was observed that 14 percent of visual evoked potential, 40 percent of cerebrospinal fluid (CSF) oligoclonal band review and one percent of magnetic resonance imaging examinations used in diagnosis of MS can't be done. There was significant differences between regions about feasibility of CSF OCB. Sixty one percent of participants thought to start immunomodulatory treatment to typical relapsing-remitting multiple sclerosis patients, filled in the Mc Donald diagnostic criteria and had two attack story. Conclusion: As all the world, in Turkey being very much difference about clinical, radiological and laboratory features of MS lead to the neurology experts work hard and the emergence of different applications about the disease diagnosis and treatment plan.en_US
dc.description.woscitationindexEmerging Sources Citation Index
dc.identifier.endpage128en_US
dc.identifier.issn1301-062X
dc.identifier.issn1309-2545
dc.identifier.issue3en_US
dc.identifier.scopusqualityQ4
dc.identifier.startpage124en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/38447
dc.identifier.volume15en_US
dc.identifier.wosWOS:000217503300004
dc.language.isoenen_US
dc.publisherTurkish Neurological Societyen_US
dc.relation.ispartofTurkish Journal of Neurologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMultiple Sclerosisen_US
dc.subjectDiagnosisen_US
dc.subjectTherapyen_US
dc.titleGeneral Approach to Diagnosis and Treatment of Multiple Sclerosis in Turkeyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files